Zhang Xiaoling, Li Jian, Wang Dongxin. Anesthetic Management of Patients with Anti-N-methyl-D-aspartate Receptor Encephalitis: A Report of Two Cases[J].Chinese Medical Sciences Journal, 2017, 32(1): 62-64.
Dalmau J, Tüzün E, Wu HY, et al.Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007; 61:25-36.
2.
Wandinger KP, Saschenbrecker S, Stoecker W, et al.Anti-NMDA-receptor encephalitis: a severe, multistage, treatable disorder presenting with psychosis. J Neuroim- munol 2011; 231:86-91.
3.
LapébieFX, Kennek C, Magy L, et al. Potential side effect of propofol and sevoflurane for anesthesia of anti-NMDA- R encephalitis. BMC Anesthesiol 2014; 14:5.
4.
Broderick DK, Raines DE, Nanji KC.Total intravenous anesthesia using N-methyl-D-aspartate (NMDA) receptor- sparing drugs in a patient with anti-NMDA receptor ence- phalitis. A A Case Rep 2014; 2:83-5.
5.
Petrenko AB, Yamakura T, Sakimura K, et al.Defining the role of NMDA receptors in anesthesia: are we there yet? Eur J Pharmacol 2014; 723:29-37.
6.
Titulaer MJ, McCracken L. Treatment and prognostic factors for long-term outcome in patients with anti-N- Methyl-D-Aspartate (NMDA) receptor encephalitis: a cohort study. Lancet Neurol 2013; 12:157-65.
7.
Dalmau J, Gleichman AJ, Hughes EG, et al.Anti-NMDA- receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008; 7:1091-8.
8.
Solt K, Eger EI 2nd, Raines DE. Differential modulation of human N-methyl-D-aspartate receptors by structurally diverse general anesthetics. Anesth Analg 2006; 102: 1407-11.
9.
Pryzbylkowski PG, Dunkman WJ, Liu R, et al.Case report: anti-N-methyl-D-aspartate receptor encephalitis and its anesthetic implications. Anesth Analg 2011; 113:1188-91.
10.
Riker RR, Shehabi Y, Bokesch PM, et al.Dexmedetomidine vs. midazolam for sedation of critically ill patients: a randomized trial. JAMA 2009; 301:489-99.